Methylene Blue: The Biohacker's Cognitive Edge

What Is Methylene Blue?

First synthesized in 1876 and used as the first synthetic drug in clinical medicine, methylene blue is now one of the most discussed cognitive performance compounds in biohacking communities. As a redox cycling agent, it can both accept and donate electrons — acting as an auxiliary electron carrier in the mitochondrial respiratory chain.

The Mitochondrial Mechanism

Methylene blue supports ATP production at multiple points:

• Accepts electrons from NADH and donates them to cytochrome c, bypassing damaged complexes in the electron transport chain.
• Acts as a potent antioxidant within mitochondria, neutralizing reactive oxygen species that damage the respiratory chain.
• Enhances Complex IV (cytochrome c oxidase) activity — the final ATP-producing step.

The brain — consuming 20% of total body energy — is a primary beneficiary of improved mitochondrial efficiency.

Cognitive Research

A human study published in Radiology (2016) used fMRI to show that a single low dose of methylene blue increased sustained attention performance and altered activation in memory-associated brain regions — one of the first controlled demonstrations in healthy humans. Animal models consistently show improved memory consolidation at low doses.

The Critical Dose Variable

Methylene blue has a striking dose-response curve: at very low doses (0.5–4mg/kg in research), it produces beneficial cognitive and mitochondrial effects. At higher doses, these effects diminish or reverse. Most human protocols use fixed low doses of 10–30mg. Pharmaceutical grade purity is essential — industrial grades contain impurities unsuitable for consumption.

The Bottom Line

Methylene blue operates at the most fundamental level of cellular energy. For evidence-informed cognitive performance, SUPPLI-X Methylene Blue delivers pharmaceutical-grade purity at precision low doses — formulated for the serious optimizer. Fuel your cognitive edge.